Award type :
Product Development Award
Product Development Award
Product type :
Diagnostics
Diagnostics
Award year :
2021
2021
Project start date :
06 / 07 / 2021
06 / 07 / 2021
Project end date :
05 / 31 / 2022
05 / 31 / 2022
Project duration (months) :
12
12
Development stage :
Early Validation
Early Validation
Target disease :
COVID-19
COVID-19
Region served :
Low- and Middle-Income Countries
Low- and Middle-Income Countries
Recipient organization / Country of funding recipient organization :
Sugentech / Republic of Korea
Sugentech / Republic of Korea
Collaborator(s) / Country :
Modori-C / Republic of Korea
Modori-C / Republic of Korea
Funding amount(KRW) :
455,000,000
455,000,000
Sugentech is collaborating with Modori-C for the development of an integrated digital health application and platform for COVID-19 diagnosis, self-assessment, and monitoring. The project aims to develop SurearlySmart Pro as an infectious disease diagnosis platform to support antigen and antibody testing as well as analytical and clinical validation. The mobile application incorporates a symptom checker, clinical guidelines for patients with self-assessment, and GPS tracking.